Scopus BioPharma's total assets for Q were $497.55K, a decrease of -68.97% from the previous quarter. SCPS total liabilities were $11.00M for the fiscal quarter, a 18.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.